These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31097457)

  • 41. Doping in Two Elite Athletics Competitions Assessed by Randomized-Response Surveys.
    Ulrich R; Pope HG; Cléret L; Petróczi A; Nepusz T; Schaffer J; Kanayama G; Comstock RD; Simon P
    Sports Med; 2018 Jan; 48(1):211-219. PubMed ID: 28849386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elite athletes' attitudes towards the use of placebo-induced performance enhancement in sports.
    Bérdi M; Köteles F; Hevesi K; Bárdos G; Szabo A
    Eur J Sport Sci; 2015; 15(4):315-21. PubMed ID: 25189187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
    Overbye M; Wagner U
    Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clean Olympians? Doping and anti-doping: the views of talented young British athletes.
    Bloodworth A; McNamee M
    Int J Drug Policy; 2010 Jul; 21(4):276-82. PubMed ID: 20056401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Androgens and athletic performance of elite female athletes.
    Bermon S
    Curr Opin Endocrinol Diabetes Obes; 2017 Jun; 24(3):246-251. PubMed ID: 28234801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anabolic steroids in sport.
    VanHelder WP; Kofman E; Tremblay MS
    Can J Sport Sci; 1991 Dec; 16(4):248-57. PubMed ID: 1663826
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of nutritional supplements by Danish elite athletes and fitness customers.
    Solheim SA; Nordsborg NB; Ritz C; Berget J; Kristensen AH; Mørkeberg J
    Scand J Med Sci Sports; 2017 Aug; 27(8):801-808. PubMed ID: 27264018
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Performance-enhancing drugs and the Olympics.
    Watson CJ; Stone GL; Overbeek DL; Chiba T; Burns MM
    J Intern Med; 2022 Feb; 291(2):181-196. PubMed ID: 35007384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician.
    Angell PJ; Chester N; Sculthorpe N; Whyte G; George K; Somauroo J
    Br J Sports Med; 2012 Nov; 46 Suppl 1():i78-84. PubMed ID: 23097484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adolescent elite athletes' cigarette smoking, use of snus, and alcohol.
    Martinsen M; Sundgot-Borgen J
    Scand J Med Sci Sports; 2014 Apr; 24(2):439-46. PubMed ID: 22830488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A retrospective 30-year follow-up study of former Swedish-elite male athletes in power sports with a past anabolic androgenic steroids use: a focus on mental health.
    Lindqvist AS; Moberg T; Eriksson BO; Ehrnborg C; Rosén T; Fahlke C
    Br J Sports Med; 2013 Oct; 47(15):965-9. PubMed ID: 23613517
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Nutritional supplements in sports - sense, nonsense or hazard?].
    Parr MK; Schmidtsdorff S; Kollmeier AS
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Mar; 60(3):314-322. PubMed ID: 28058459
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discussing prevalence, impacts, and treatment of substance use disorders in athletes.
    Gil F; de Andrade AG; Castaldelli-Maia JM
    Int Rev Psychiatry; 2016 Dec; 28(6):572-578. PubMed ID: 27534440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prediction profiles for nutritional supplement use among young German elite athletes.
    Dietz P; Ulrich R; Niess A; Best R; Simon P; Striegel H
    Int J Sport Nutr Exerc Metab; 2014 Dec; 24(6):623-31. PubMed ID: 24901677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects.
    Heuberger JAAC; Cohen AF
    Sports Med; 2019 Apr; 49(4):525-539. PubMed ID: 30411235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of anabolic androgenic steroid use by elite athletes and by members of the general public.
    Anawalt BD
    Mol Cell Endocrinol; 2018 Mar; 464():21-27. PubMed ID: 28943276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Misuse of prescription stimulant medication in a sample of college students: examining differences between varsity athletes and non-athletes.
    Gallucci AR; Martin RJ
    Addict Behav; 2015 Dec; 51():44-50. PubMed ID: 26217928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Substance Use and Its Impact on Athlete Health and Performance.
    Stull T; Morse E; McDuff DR
    Psychiatr Clin North Am; 2021 Sep; 44(3):405-417. PubMed ID: 34372997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Associations between physical and cognitive doping--a cross-sectional study in 2.997 triathletes.
    Dietz P; Ulrich R; Dalaker R; Striegel H; Franke AG; Lieb K; Simon P
    PLoS One; 2013; 8(11):e78702. PubMed ID: 24236038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.